Neisseria gonorrhoeae and Chlamydia trachomatis among human immunodeficiency virus-infected women

Sexually Transmitted Diseases

Volumn 35, Issue 10, 2008, Pages 859-861

  Page, Kathleen R ^a   Moore, Richard D ^a,b   Wilgus, Barbara ^a   Gindi, Renee ^b   Erbelding, Emily J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL ASSESSMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LOGISTIC REGRESSION ANALYSIS; NEISSERIA GONORRHOEAE; NEISSERIACEAE INFECTION; NUCLEIC ACID AMPLIFICATION; PATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; RISK FACTOR; RISK REDUCTION; SCREENING; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; VIRUS TRANSMISSION; ADULT; COHORT ANALYSIS; FEMALE; GONORRHEA; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; UNITED STATES; VIROLOGY;

ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COHORT STUDIES; FEMALE; GONORRHEA; HIV INFECTIONS; HUMANS; MARYLAND; NEISSERIA GONORRHOEAE; PREVALENCE; RISK FACTORS;

EID: 54449096907     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31817bbcb4     Document Type: Article

References (14)

1. Aberg JA, Gallant JE, Anderson J, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2004; 39:609-629.
2. U.S. Preventive Services Task Force. Screening for chlamydial infection: Recommendations and rationale. Am J Prev Med 2001; 20(S1):90-94.
3. U.S. Preventive Services Task Force. Screening for Gonorrhea: Recommendation statement. Am J Fam Med 2005; 3:263-267.
4. Ghys PD, Fransen K, Diallo MO, et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire. AIDS 1997; 11:F85-F93.
5. Moore RD. Understanding the clinical and economic outcomes of HIV therapy: The Johns Hopkins HIV clinical practice cohort. J Acquir Immun Defic Syndr Hum Retrovirol 1998; 17S(suppl 1):S38-S41.
6. Erbelding EJ, Chung SE, Kamb ML, et al. New sexually transmitted diseases in HIV-infected patients: Markers for ongoing HIV transmission behavior. J Acquir Immun Defic Syndr 2003; 33:247-252.
7. Manning SE, Pfeiffer MR, Nash D, et al. Incident sexually transmitted infections among persons living with diagnosed HIV/AIDS in New York City, 2001-2002: A population-based assessment. Sex Transm Dis 2007; 34:1008-1015.
8. Datta SD, Sternberg M, Johnson RE, et al. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med 2007; 147:89-96.
9. Katz AR, Effler PV, Ohye RG, et al. False-positive gonorrhea test results with a nucleic acid amplification test: The impact of low prevalence on positive predictive value. Clin Infect Dis 2004; 38:814-819.
10. CDC. STD Surveillance, 2005. Available at: http://www.cdc.gov/std/stats/ Accessed 10/2/07. 2005.
11. Farley TA, Cohen DA, Wu SY, et al. The value of screening for sexually transmitted diseases in an HIV clinic. J Acquir Immun Defic Syndr 2003; 33:642-648.
12. Klausner JD, Stanley H, Stansell J. STD screening among HIV-infected patients in care, San Francisco. AIDS Patient Care STDS 2001; 15:73-76.
13. St Lawrence JS, Montano DE, Kasprzyk D, et al. STD screening, testing, case reporting, and clinical and partner notification practices: a national survey of US physicians. Am J Public Health 2002; 92:1784-1788.
14. Tao G, Irwin KL. Receipt of HIV and STD testing services during routine general medical or gynecological examinations: Variations by patient sexualrisk behaviors. Sex Transm Dis 2008; 35:167-171.